Anika Therapeutics | Resultado Líquido



Net Income Alterar Data
Abbott USD 1.33B 7.9B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Insmed USD -256583000 21.04M 2025-03
Integra LifeSciences USD -25293000 44.73M 2025-03
J&J USD 11B 7.57B 2025-03
Ligand Pharmaceuticals USD -42451000 11.36M 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Merit Medical Systems USD 30.15M 2.2M 2025-03
Sanofi EUR 1.87B 1.37B 2025-03
Smith & Nephew USD 198M 16M 2024-12
Stryker USD 654M 108M 2025-03
Veracyte USD 7.05M 1.93M 2025-03
Xencor USD -48418000 5.06M 2025-03
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12



Anika Therapeutics Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.